Tharimmune Inc (THAR) Stock Price

1.35 ▲ +0.03 (+2.27%)
Open: 1.26 Vol: 23.63K Day's range: 1.26 - 1.35 Aug 15, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
THAR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.32▲ 1.32▲ 1.32▲ 1.32▲ 1.40▼
MA10 1.29▲ 1.31▲ 1.31▲ 1.28▲ 1.50▼
MA20 1.34▼ 1.39▼ 1.35▼ 1.37▼ 1.42▼
MA50 1.38▼ 1.33▲ 1.35▼ 1.52▼ 1.83▼
MA100 1.40▼ 1.49▼ 1.49▼ 1.44▼ N/A    
MA200 1.49▼ 1.48▼ 1.49▼ 1.73▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ -0.008▼ -0.003▼ 0.010▲ 0.058▲
RSI 48.405▼ 49.216▼ 50.052▲ 46.358▼ 40.274▼
STOCH 71.105     58.134     55.507     37.470     32.528    
WILL %R -33.333     -40.984     -60.870     -60.784     -75.309▼
CCI 44.105     2.988     -3.382     37.638     -52.353    
Latest Filters Detected On THAR
▼ GAP $THAR Open Gap Down %3 Set Alert
▼ GAP $THAR Open Gap Down %2 Set Alert
CDL $THAR Marubozu Candlestick Pattern Detected Set Alert
Tharimmune Inc News
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against ...
Wednesday, August 13, 2025 05:57 AM
Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and ...
Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral ...
Tuesday, August 05, 2025 06:00 AM
Company closes approximately $5.47 million in equity financing in 2Q/3Q25-TH104 potentially fills a critical National Security Need against Weaponized Fentanyl–TH023 may fulfill the promise of ...
Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors
Tuesday, August 05, 2025 05:16 AM
Tharimmune, Inc. (NASDAQ:THAR), ("Tharimmune" or the "Company), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and ...
THAR historical stock data
date open high low close volume
15/08/25 1.26 1.35 1.26 1.35 23,627
14/08/25 1.27 1.32 1.15 1.32 79,821
13/08/25 1.47 1.66 1.28 1.32 1,673,315
12/08/25 1.22 1.41 1.22 1.40 51,832
11/08/25 1.27 1.2997 1.174 1.20 44,549
08/08/25 1.26 1.26 1.234 1.234 6,256
07/08/25 1.26 1.32 1.222 1.26 18,033
06/08/25 1.24 1.2594 1.20 1.21 20,647
05/08/25 1.30 1.35 1.20 1.22 81,590
04/08/25 1.2394 1.36 1.2394 1.33 63,235
Quote Details
52wk Low:0.952
52wk High:6.39
Vol:23.63K
Avg Vol(3m):1.3M
1Y Chng:-50.37%
1M Chng:-20.12%
Add to Watch List
More Information
Index US Composite
Market Cap. 6.96M